Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence

Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence English

This Activity for

  • Resident / Fellow
  • Physician

What I will learn?

"1. To review the latest Olumiant real world evidence and demonstrate the consistency of results between this and the clinical evidence.
2. To discuss why Olumiant should be used earlier in the treatment pathway and is the perfect molecule to implement a treat to target approach.
3. To agree that Olumiant should be a good contender for JAKI of choice.

Additional items to the activity

Optional Details Type Fee
Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence Certificate

Certificate

Certificate Free
VAT 15% Included

About Organizer

Contact the organizer and they will be glad to help!

Virtual Medical Academy

was 0 SAR

Free
0%coupon Discount
  • calendar 30 Jan 2024
  • clock 12:00 pm - 01:00 pm - Saudi Arabia (+03:00)
  • quality Certificate Available
  • adjust no access Materiel
  • Registration Policy Full Course
  • Completion Role You must attend all the Sessions
  • Refund Policy No Refund
Free